Skip to main content
10x Genomics, Inc. logo

10x Genomics, Inc. — Investor Relations & Filings

Ticker · TXG ISIN · US88025U1097 LEI · 5493003Z6741WNLG7H43 US Manufacturing
Filings indexed 636 across all filing types
Latest filing 2026-01-12 Regulatory Filings
Country US United States of America
Listing US TXG

About 10x Genomics, Inc.

https://www.10xgenomics.com/

10x Genomics, Inc. is a life science technology company that develops and manufactures integrated solutions for biological research. Its systems, which include instruments, consumables, and software, enable scientists to analyze biological systems at high resolution and scale. The company's core product platforms are Chromium for high-throughput single-cell analysis with multiomic capabilities, Visium for spatial whole transcriptome analysis within morphological context, and Xenium for subcellular in situ spatial imaging of RNA and protein. These technologies empower researchers to dissect cellular heterogeneity, map spatial gene expression patterns, and decipher cellular interactions within tissues. The platforms are widely used across diverse fields, including oncology, immunology, and neuroscience, to accelerate biological discovery and advance human health.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2026-01-12 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-01-08 English
Director's Dealing 2026
Director's Dealing
2026-01-07 English
Director's Dealing 2025
Director's Dealing
2025-11-25 English
Director's Dealing 2025
Director's Dealing
2025-11-25 English
Director's Dealing 2025
Director's Dealing
2025-11-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.